Jonathan Lindner is a Cardiology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Echocardiographic Molecular Imaging for POC Detection of Ischemia
Sponsor: University of Virginia
- MCE Molecular Imaging for Myocarditis
Sponsor: University of Virginia
- Acute Microvascular Changes With LDL Apheresis
Sponsor: Oregon Health and Science University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BioMarinProgram year20252 paymentsResearch$312,936openpaymentsdata.cms.gov ↗
- LantheusProgram year20259 paymentsResearch$103,349openpaymentsdata.cms.gov ↗
- GE HEALTHCAREProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
88.5%Statin27.2%Atorvastatin Calcium70%Rosuvastatin Calcium30%Part D<11 patientsBeta blocker14.4%Carvedilol63%Metoprolol Tartrate37%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
11.5%Potassium supplement7%Potassium Chloride100%Part D<11 patientsSGLT2 inhibitor4.5%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
10 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- Rapid Point-of-Care Molecular Imaging of Immune Activation in ACS and Acute Myocarditis
University of Virginia
FY2026$802,973R01HL182839 - Ultrasound Cavitation for Facilitated Cardiac Transduction of AAV
University of Virginia
FY2026$736,438R01HL171377 - Advanced Non-invasive Imaging in the Investigation of Aortic Stenosis Pathobiology
University of Virginia
FY2026$659,193R01HL165422
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”